Glycine is an inexpensive ingredient
to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
These therapies, initially designed for type 2 diabetes, have demonstrated significant weight loss benefits, leading to their expanded use in obesity management
Managing Side Effects During Dose Increases Nausea, vomiting, and reduced appetite are among the most common side effects during early dose escalation, but they typically diminish within a few days to a week as your body adjusts
Ultimately, this strategy suppresses key immunosuppressive mediators (e.g., TGF-, IL-10), increases infiltration by M1-polarised macrophages and CD8 T cells, and upregulates MHC and costimulatory moleculescollectively establishing a durable antitumour immune milieu